Baxter International Inc.
BAX Real Time Price USDRecent trades of BAX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BAX holdings by institutional investors
Quarterly net insider trading by BAX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
-
$30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues
BAX Estimated quarterly lobbying spending
BAX Revenue by Segment or Geography
New BAX patent grants
-
Patent Title: Noise-reducing dialysis systems and methods of reducing noise in dialysis systems Apr. 07, 2015
-
Patent Title: Method to produce an immunoglobulin preparation with improved yield Mar. 31, 2015
-
Patent Title: Balanced flow dialysis machine Mar. 31, 2015
-
Patent Title: Systems and methods for performing peritoneal dialysis Mar. 31, 2015
-
Patent Title: Method for delivering particulate drugs to tissues Mar. 24, 2015
-
Patent Title: Igg stimulated remyelination of peripheral nerves Mar. 24, 2015
-
Patent Title: Method for the validatable inactivation of pathogens in a biological fluid by irradiation Mar. 24, 2015
-
Patent Title: Peritoneal dialysis patient connection system Mar. 24, 2015
-
Patent Title: Peritoneal dialysis solutions comprising glucose polymers Mar. 10, 2015
-
Patent Title: Formulation of sugar solutions for continuous ultracentrifugation for virus purification Mar. 03, 2015
-
Patent Title: Fviii peptides for immune tolerance induction and immunodiagnostics Mar. 03, 2015
-
Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Mar. 03, 2015
-
Patent Title: Transgenic non-human animals expressing human blood clotting factors and uses thereof Feb. 24, 2015
-
Patent Title: Tfpi inhibitors and methods of use Feb. 24, 2015
-
Patent Title: Polymeric benzyl carbonate-derivatives Feb. 24, 2015
-
Patent Title: Rapidly acting dry sealant and methods for use and manufacture Feb. 24, 2015
-
Patent Title: Systems and methods for performing hemodialysis Feb. 24, 2015
-
Patent Title: Multi-state alarm system for a medical pump Feb. 24, 2015
-
Patent Title: Pressure manifold system for dialysis Feb. 24, 2015
-
Patent Title: Materials and methods for conjugating a water soluble fatty acid derivative to a protein Feb. 03, 2015
-
Patent Title: Methods of purifying recombinant adamts13 and other proteins and compositions thereof Feb. 03, 2015
-
Patent Title: Medical fluid machine with supply autoconnection Feb. 03, 2015
-
Patent Title: Method to produce an immunoglobulin preparation with improved yield Jan. 27, 2015
-
Patent Title: Methods for isolating and quantifying antigen from vaccines Jan. 27, 2015
-
Patent Title: Process for making dry and stable hemostatic compositions Jan. 27, 2015
-
Patent Title: Drain and fill logic for automated peritoneal dialysis Jan. 20, 2015
-
Patent Title: Personal hemodialysis system including priming sequence and methods of same Jan. 13, 2015
-
Patent Title: System and method for detecting access disconnection Jan. 06, 2015
-
Patent Title: Removal of serine proteases by treatment with finely divided silicon dioxide Dec. 30, 2014
-
Patent Title: Dialysis system having disposable cassette Dec. 30, 2014
-
Patent Title: Conductive polymer materials and applications thereof including monitoring and providing effective therapy Dec. 30, 2014
-
Patent Title: Acoustic access disconnection systems and methods Dec. 30, 2014
-
Patent Title: Peritoneal dialysis machine Dec. 02, 2014
-
Patent Title: Multiple drug infusion system and method Nov. 25, 2014
-
Patent Title: Hemodialysis system including on-line dialysate generation Nov. 25, 2014
-
Patent Title: Removal of serine proteases by treatment with finely divided silicon dioxide Nov. 18, 2014
-
Patent Title: Battery management system Nov. 18, 2014
-
Patent Title: Infusion pump with multiple orientation display Nov. 18, 2014
-
Patent Title: Smart patient transfer set for peritoneal dialysis Nov. 11, 2014
-
Patent Title: Hemodialysis system with multiple cassette interference Nov. 11, 2014
-
Patent Title: Formulations of recombinant furin Nov. 04, 2014
-
Patent Title: Method for preparing fmoc-based hydrolysable linkers Oct. 28, 2014
-
Patent Title: Dialysis method including wireless patient data Oct. 28, 2014
-
Patent Title: Dialysis system having video display with ambient light adjustment Oct. 28, 2014
-
Patent Title: Non-invasive radio frequency liquid level and volume detection system using phase shift Oct. 28, 2014
-
Patent Title: Temperature compensation for pneumatic pumping system Oct. 21, 2014
-
Patent Title: Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis Oct. 21, 2014
-
Patent Title: Method for producing continuous cell lines Oct. 21, 2014
-
Patent Title: Methods and assays for oversulfated glycosaminoglycans Oct. 21, 2014
-
Patent Title: Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions Oct. 14, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BAX from public contracts
Recent insights relating to BAX
Recent picks made for BAX stock on CNBC
ETFs with the largest estimated holdings in BAX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BAX stock a Buy, Sell, or Hold?
- What is the price target for $BAX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BAX stock?
- Who owns the most shares of $BAX stock?
- What funds own $BAX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BAX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
- Address Deerfield, IL
- Market Cap 8.9 billion
- Employees 37,500
- Industrial Classification Surgical & Medical Instruments & Apparatus
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|